3.94
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LFMD?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$3.935
Offen:
$3.98
24-Stunden-Volumen:
612.50K
Relative Volume:
0.53
Marktkapitalisierung:
$189.66M
Einnahmen:
$193.06M
Nettoeinkommen (Verlust:
$-22.51M
KGV:
-6.1563
EPS:
-0.64
Netto-Cashflow:
$10.63M
1W Leistung:
+30.83%
1M Leistung:
+41.19%
6M Leistung:
-32.33%
1J Leistung:
-30.65%
Lifemd Inc Stock (LFMD) Company Profile
Firmenname
Lifemd Inc
Sektor
Branche
Telefon
(866) 351-5907
Adresse
236 FIFTH AVENUE, NEW YORK
Compare LFMD vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
LFMD
Lifemd Inc
|
3.94 | 189.41M | 193.06M | -22.51M | 10.63M | -0.64 |
|
VEEV
Veeva Systems Inc
|
178.91 | 29.72B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
50.48 | 8.85B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
37.63 | 7.42B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
75.78 | 6.56B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
24.14 | 4.72B | 1.10B | 112.09M | 283.19M | 0.6096 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-18 | Bestätigt | BTIG Research | Buy |
| 2024-12-10 | Eingeleitet | Lake Street | Buy |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-08-23 | Fortgesetzt | B. Riley Securities | Buy |
| 2024-06-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-11-30 | Eingeleitet | Craig Hallum | Buy |
| 2023-07-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-07-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-03-10 | Eingeleitet | Colliers Securities | Buy |
| 2021-10-04 | Fortgesetzt | B. Riley Securities | Buy |
Alle ansehen
Lifemd Inc Aktie (LFMD) Neueste Nachrichten
HC Wainwright Issues Positive Forecast for LifeMD Earnings - MarketBeat
LifeMD outlines $250M+ annualized revenue run rate target by Q4 2026 amid record GLP-1 demand and expanded partnerships - MSN
LifeMD (LFMD) Valuation Check After Earnings Beat Guidance Update And Wegovy Partnership - simplywall.st
Hims & Hers Plunges 29.4% in Three Months: How to Play the Stock? - TradingView
Freedom Capital Markets raises LifeMD stock price target on forecast boost By Investing.com - Investing.com South Africa
Freedom Capital Markets raises LifeMD stock price target on forecast boost - Investing.com India
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF), Centene (CNC) and LifeMD (LFMD) - The Globe and Mail
LifeMD: Wegovy Pill, Net Cash, And Low Multiple Sets Up Longs For Possible Alpha - Seeking Alpha
LifeMD, Inc. 2025 Annual Report: Virtual Healthcare, Telehealth Growth, and Integrated Pharmacy Platform 101 - Minichart
HC Wainwright Increases LifeMD (NASDAQ:LFMD) Price Target to $10.00 - MarketBeat
H.C. Wainwright raises LifeMD stock price target to $10 on results - Investing.com Australia
LifeMD (LFMD): HC Wainwright Raises Price Target While Maintaini - GuruFocus
Cantor Fitzgerald Maintains Overweight on LifeMD, Inc. (LFMD) March 2026 - Meyka
LifeMD (LFMD) Trailing Losses Narrow To US$14.6m Challenging Bearish Profitability Narratives - simplywall.st
LifeMD 10-K: Telehealth revenue $194.1M, Net income $15.62M - TradingView
LifeMD (LFMD) Soars After Strong Q4 Results and Positive Outlook - GuruFocus
LifeMD soars as Cantor Fitzgerald reportedly reiterates Overweight rating following solid Q4 print - Seeking Alpha
Cantor Fitzgerald reiterates Overweight on LifeMD stock, $15 target By Investing.com - Investing.com Canada
Cantor Fitzgerald reiterates Overweight on LifeMD stock, $15 target - Investing.com
BTIG Research Reiterates Buy Rating for LifeMD (NASDAQ:LFMD) - MarketBeat
LifeMD (LFMD) Receives Analyst Rating Reiteration from BTIG | LF - GuruFocus
LifeMD options imply 10.9% move in share price post-earnings - TipRanks
LifeMD rises on Q4 2025 beats, 2026 revenue guidance midpoint above consensus - MSN
LifeMD Inc (LFMD) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
LifeMD Q4 2025 Earnings Call Transcript - MarketBeat
LifeMD Inc (LFMD) Q4 2025 Earnings Call Highlights: Strong Reven - GuruFocus
LifeMD (LFMD) Reports Strong Growth and Strategic Partnerships - GuruFocus
LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue Estimates - Bitget
LifeMD Q4 Earnings Call Highlights - MarketBeat
LifeMD (LFMD) Shares Surge After Beating Q4 2025 Expectations - GuruFocus
LifeMD earnings beat by $0.03, revenue fell short of estimates - Investing.com Canada
LifeMD: Q4 Earnings Insights - Benzinga
LifeMD reports Q4 EPS 41c, consensus 3c - TipRanks
LifeMD (LFMD) Reports Strong Q4 Revenue and Expanding Telehealth Subscriber Base - GuruFocus
LifeMD (LFMD) Projects Q1 EBITDA Loss, Anticipates Rebound in Q2 - GuruFocus
LifeMD (LFMD) Projects Strong Financial Growth for 2026 - GuruFocus
LifeMD surges 11.5% on Q4 earnings beat, FY guidance - Investing.com South Africa
LifeMD (NASDAQ:LFMD) Releases Quarterly Earnings Results, Beats Expectations By $0.42 EPS - MarketBeat
LifeMD Issues 2026 Outlook Amid Strong 2025 Growth - TipRanks
LIFEMD ($LFMD) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative
LifeMD 2025 revenue jumps 25% to $194M, guides 2026 - National Today
LifeMD Q4 revenue rises but misses estimates - TradingView
LifeMD Reports Fourth Quarter and Full Year 2025 Results - Yahoo Finance
BREAKING: LFMD Reports Q4 Earnings - AlphaStreet
LifeMD’s GLP-1 Growth Looks Real, But The Stock’s Still Cheap - Finimize
LifeMD Inc expected to post a loss of 3 cents a shareEarnings Preview - TradingView
Earnings Outlook For LifeMD - Benzinga
Earnings To Watch: LifeMD Inc (LFMD) Reports Q4 2025 Result - GuruFocus
LFMDP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
LifeMD to Participate in Two Investor Conferences During March - Bitget
LFMD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Finanzdaten der Lifemd Inc-Aktie (LFMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):